Category: Q&A

Serotonin, Gut-Brain-Microbiome Axis and an Inspired Young Scientist. How a Core Facility is Born. Q&A with Prof. Beate Niesler, Institute of Human Genetics, University of Heidelberg, Germany.

Imagine you are setting up for an interview with a prominent professor at the University of Heidelberg in Germany, in which you will focus on how a scientific interest triggered the need for new technology, and how acquiring that technology...

/ September 14, 2020

Molecular Signatures of Antibody-Mediated Rejection and Graft Outcome After Kidney Transplantation. Q&A with Dr. Dela Golshayan, M.D., Ph.D.

When Newsweek Magazine rates you the 9th best Hospital in the World, you know you are doing something remarkable!  Located in Lausanne, Switzerland, Lausanne University Hospital (CHUV) sits on Lake Geneva and is surrounded by snowcapped and picturesque Swiss mountain peaks....

/ August 31, 2020

All Things Grants. Q&A with a Grant Reviewer and two Grant Writers – Tips & Tricks for Success.

"An advice I would give to a beginner grant writer is to take the reviewer by hand, take him one step at the time in a logical fashion through that grant proposal." Dr. Thompson Grant writing is an integral part...

/ August 17, 2020

Excellence, Cooperation, and Passion Come Together to Serve the Scientific Community. Q&A with Dr. Peter O’Toole, Director of the Bioscience Technology Facility, University of York.

Dr. Peter O'Toole, Ph.D., is the director of the Bioscience Technology Facility at the University of York in England, where he established and still leads the Imaging and Cytometry Laboratory, one of the top bioscience technology facilities in Europe. His lab is an...

/ August 3, 2020

Statistically Significant Results without the Headache. Q&A with Sarah Church, PhD, Senior Scientist at NanoString.

Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString, and one of the warmest people you can run into in the hallway. She is also...

/ July 27, 2020